Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes

Journal: Nature Medicine

Published: 2020-06-22

DOI: 10.1038/s41591-020-0933-1

Affiliations: 16

Authors: 26

Go to article
Institutions Share
Department of Medical Oncology, DFCI, United States of America (USA) 0.23
Genitourinary Cancer Treatment Center, DFCI, United States of America (USA) 0.23
Center for Functional Cancer Epigenetics (CFCE), DFCI, United States of America (USA) 0.14
Princess Margaret Cancer Centre, U of T, Canada 0.10
Cancer Center, MGH, United States of America (USA) 0.04
Brigham and Women's Hospital (BWH), United States of America (USA) 0.04
Broad Institute of MIT and Harvard, United States of America (USA) 0.03
Dipartimento di Medicina Interna e Specialità Mediche (DIMI), Università di Genova, Italy 0.03
Department of Statistics, UBC, Canada 0.02
BC Children’s Hospital Research Institute, Canada 0.02
IRCCS Azienda Ospedaliera Universitaria San Martino, Italy 0.02
Division of Renal (Kidney) Medicine, BWH, United States of America (USA) 0.02
Roger Williams Medical Center (RWMC), BU, United States of America (USA) 0.02
Harvard Department of Biostatistics (BIO), United States of America (USA) 0.02
Department of Data Sciences, DFCI, United States of America (USA) 0.02
Department of Medical Biophysics, U of T, Canada 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER